Nutex Health Inc. (NASDAQ: NUTX) Investigation: Edelson Lechtzin LLP Seeks Investors with Substantial Losses

Edelson Lechtzin LLP is investigating Nutex Health Inc. for potential violations of federal securities laws due to allegations of providing misleading business information to investors. The investigation follows a report by Blue Orca Capital raising concerns about Nutex's relationship with HaloMD, a third-party vendor sued for allegedly engaging in a fraudulent scheme to defraud insurance companies. Nutex's stock price fell 10.05% after the report was published.

HOUSTON, July 2, 2025 — Edelson Lechtzin LLP has announced an investigation into potential violations of federal securities laws involving Nutex Health Inc. ("Nutex") (NASDAQ: NUTX). The investigation stems from allegations that Nutex provided misleading business information to the investing public. The firm encourages investors who suffered substantial losses to contact them for more information [1].

The investigation follows a report by Blue Orca Capital, which raised concerns about Nutex's relationship with HaloMD, a third-party vendor. HaloMD has been named in three federal lawsuits alleging it engaged in a fraudulent scheme to defraud insurance companies. Specifically, the report alleges that HaloMD helped Nutex generate "unsustainably high" reimbursement rates through the arbitration process outlined in the No Surprises Act (NSA) [2].

Following the publication of the Blue Orca report on July 22, 2025, Nutex's stock price fell by $11.18 per share, or 10.05%, to close at $100.01 per share [1]. Blue Orca's report also highlighted Nutex's dramatic revenue growth, which it linked to HaloMD's alleged tactics. The report warned that Nutex could face significant legal and financial risks, including potential clawbacks from insurers [2].

Nutex, a healthcare services company that develops and operates micro-hospitals and outpatient facilities, has not yet responded publicly to the allegations. The company manages independent physician associations through its cloud-based platform and owns and leases healthcare real estate across the United States [1].

Edelson Lechtzin LLP is a national class action law firm based in suburban Philadelphia with offices in Pennsylvania and California. The firm specializes in cases involving securities and investment fraud, antitrust laws, employee benefit plans, wage theft, data security breaches, and consumer fraud [1].

For more information or to provide relevant information, investors can contact attorney Eric Lechtzin of Edelson Lechtzin LLP by calling 844-563-5550 or via email at elechtzin@edelson-law.com [1].

References:

[1] https://www.marketscreener.com/news/investigation-alert-edelson-lechtzin-llp-announces-an-investigation-of-nutex-health-inc-nasdaq-n-ce7c5fdbdf88f221
[2] https://stocktwits.com/news-articles/markets/equity/blue-orca-shorts-nutex-over-ties-to-alleged-insurance-fraud-scheme/ch8MpZwR5tn